Probiotics in Infants With Cyanotic Congenital Heart Disease

Completed · Not applicable · Has a placebo group

Conditions studied: Cyanotic Congenital Heart Disease

In brief

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. It is unknown how congenital heart disease affects the development of bacterial colonization of the intestines. It is also unknown whether probiotics will change the bacteria in the intestine of infants with heart disease to become more like those of healthy infants without heart disease. This pilot trial is designed to address these two questions.

Key facts

Study ID

NCT01018472

Run by

University of California, Davis

People needed

12

Starts

2009-11-01

Expected to finish

2011-12-01

Last updated by the study team

2014-12-02

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cyanotic congenital heart disease
• Term infant
• Born at or transferred to UC Davis Children's hospital

You may not qualify if…

• Congenital anomalies of the intestinal tract

Where it is running

• UC Davis Children's Hospital — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.